ROSETTA GENOMICS LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0001 USD | +9,900.00% |
|
-.--% | -.--% |
| 2018 | Genoptix, Inc. cancelled the acquisition of Rosetta Genomics Ltd.. | CI |
| 2018 | Rosetta Genomics Ltd.(NasdaqCM:ROSG) dropped from NASDAQ Composite Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 592 | - | - | - | - | - | |
| 5.11TCr | - | |||||
| 3.89TCr | ||||||
| 3.88TCr | ||||||
| 2.67TCr | ||||||
| 2.63TCr |
